Table 3 The predictive value of CTCs before and during the course of treatment in colorectal cancer patients when compared with 6 months clinical outcome assessed by radiographic images
From: Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients
Variable | Odds ratio (95%CI) | P |
|---|---|---|
CTCs before therapy (pos vs neg) | 6.22 (1.07-36.21) | 0.042 |
CTCs after 1–4 weeks of therapy (pos vs neg) | 5.50 (1.22-24.81) | 0.027 |
CTCs after 5–8 weeks of therapy (pos vs neg) | 7.94 (1.60-39.42) | 0.011 |
CTCs after 9–12 weeks of therapy (pos vs neg) | 14.00 (2.60-75.41) | 0.002 |
CTCs fluctuations during therapy (increase vs decrease) | 20.57 (2.17-194.95) | 0.008 |